$4.4 M

GOVX Mkt cap, 19-Sep-2018
GeoVax Net income (Q2, 2018)-1.3 M
GeoVax EBIT (Q2, 2018)-1.3 M
GeoVax Cash, 30-Jun-2018191 K
GeoVax EV4.2 M

GeoVax Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

R&D expense

2.9 m1.8 m1.7 m2 m2 m

General and administrative expense

1.8 m1.8 m1.4 m2.1 m1.2 m

Operating expense total

4.7 m3.6 m3.1 m4.1 m3.2 m

EBIT

(2.3 m)(2.7 m)(2.7 m)(3.3 m)(2.2 m)

Interest income

4.5 k4.1 k5.5 k1.7 k4.3 k

Net Income

(2.3 m)(2.7 m)(2.7 m)(3.3 m)(2.2 m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

R&D expense

516.2 k425.5 k403.6 k384.7 k378.5 k438 k397.6 k683.9 k551.8 k487 k859.2 k

General and administrative expense

344.9 k411.8 k401.4 k364.9 k335.9 k906.5 k344.8 k220.7 k292.7 k357.2 k716.4 k

Operating expense total

861.1 k837.3 k805.1 k749.5 k714.5 k1.3 m742.4 k904.6 k844.5 k844.2 k1.6 m

EBIT

(680.6 k)(515.2 k)(701.6 k)(678.1 k)(621.3 k)(1.3 m)(576.1 k)(464.5 k)(548.7 k)(622.9 k)(1.3 m)

Interest expense

208 833

Interest income

1.1 k711 1.2 k1.9 k1.4 k630 279 340 386 1.3 k3 k

Net Income

(679.5 k)(514.5 k)(700.5 k)(676.2 k)(619.9 k)(1.3 m)(575.8 k)(464.2 k)(548.3 k)(621.8 k)(1.3 m)

GeoVax Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.5 m1.1 m1.1 m454 k312.7 k

Inventories

43.6 k44.5 k56.6 k62.3 k

Current Assets

2.7 m1.2 m1.2 m544.4 k448.1 k

PP&E

120.2 k96.7 k83.6 k54.8 k31.2 k

Total Assets

2.8 m1.3 m1.3 m610.2 k490.2 k

Accounts Payable

155.9 k55.6 k100.9 k75.6 k77.6 k

Current Liabilities

312.3 k187 k127 k369.8 k811.3 k

Common Stock

32 k55.2 k

Preferred Stock

60.6 k

Additional Paid-in Capital

28.2 m30.8 m32.6 m34.9 m35.6 m

Retained Earnings

(29.8 m)(32.5 m)(35.7 m)(37.9 m)

Total Equity

1.2 m240.4 k(321.1 k)

Financial Leverage

1.1 x2.5 x-1.5 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Cash

1.4 m862.2 k3.1 m2.5 m1.8 m669.5 k215.1 k511.1 k166.7 k571.2 k191 k

Current Assets

1.4 m926.4 k3.2 m2.6 m1.9 m709 k258.8 k602.2 k240.4 k802.3 k339.1 k

PP&E

103.6 k113.2 k105.3 k98.1 k90.8 k76.4 k69.2 k62 k52.3 k26.2 k21.2 k

Total Assets

1.5 m1.1 m3.4 m2.7 m2 m796.5 k339.1 k675.2 k303.7 k839.5 k371.4 k

Accounts Payable

115.4 k82.2 k45.9 k111 k42.5 k102.7 k39.1 k33.5 k150.9 k54 k66 k

Short-term debt

1 k4.2 k

Current Liabilities

237.5 k170.2 k216.7 k181.1 k118.2 k166.4 k180.2 k252.6 k547.9 k919.4 k1.1 m

Total Debt

1 k4.2 k

Total Liabilities

968.4 k1.1 m

Additional Paid-in Capital

28.7 m28.9 m32.5 m32.6 m32.6 m33.3 m33.5 m34.2 m35 m36.2 m36.6 m

Retained Earnings

(30.5 m)(31.2 m)(31.8 m)(33.8 m)(34.3 m)(34.8 m)(36.3 m)(38.5 m)(39.2 m)

Total Equity

3.1 m2.5 m1.9 m630 k158.9 k422.6 k(244.2 k)(128.9 k)(742.7 k)

Financial Leverage

1.1 x1.1 x1.1 x1.3 x2.1 x1.6 x-1.2 x-6.5 x-0.5 x

GeoVax Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(2.3 m)(2.7 m)(2.7 m)(3.3 m)(2.2 m)

Depreciation and Amortization

78.9 k69 k28.9 k28.8 k28 k

Inventories

(1.3 k)(934 )(12.1 k)(5.6 k)

Accounts Payable

(14.7 k)(125.3 k)(60 k)242.9 k441.4 k

Cash From Operating Activities

(1.7 m)(2.3 m)(2.7 m)(1.9 m)(1.7 m)

Purchases of PP&E

(86.6 k)(35.5 k)(15.9 k)(4.4 k)

Cash From Investing Activities

(86.6 k)(35.5 k)(15.9 k)(4.4 k)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(679.5 k)(514.5 k)(700.5 k)(676.2 k)(619.9 k)(1.3 m)(575.8 k)(464.2 k)(548.3 k)(621.8 k)(1.3 m)

Depreciation and Amortization

5 k9.9 k

Accounts Payable

115.4 k82.2 k45.9 k111 k42.5 k102.7 k39.1 k33.5 k150.9 k107.1 k252.8 k

Cash From Operating Activities

(381.6 k)(761.8 k)

Cash From Financing Activities

640 k

GeoVax Ratios

USDY, 2018

EV/EBIT

-3.3 x

EV/CFO

-5.5 x

Financial Leverage

-0.5 x
Report incorrect company information